VINGRAF -0.5 Capsule Kenya - English - Pharmacy and Poisons Board

vingraf -0.5 capsule

emcure pharmaceuticals limited emcure house, t-184 midc, bhosari, pune, 411026, - tacrolimus capsules usp - capsule - tacrolimus capsules usp 0.5 mg/capsule - tacrolimus

Inbec Tablet, Film-coated 600/50/300 mg Tanzania - English - Tanzania Medicinces & Medical Devices Authority

inbec tablet, film-coated 600/50/300 mg

emcure pharmaceuticals limited, india - abacavir,dolutegravir , lamivudine - tablet, film-coated - 600/50/300 mg

Atazor-R tablets film-coated Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

atazor-r tablets film-coated

emcure pharmaceuticals ltd. - atazanavir sulphate, ritonavir - tablets film-coated - 300mg+ 100mg

Tavin-EM tablets film-coated Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

tavin-em tablets film-coated

emcure pharmaceuticals ltd. - tenofovir (tenofovir disoproxil fumarate), emtricitabine - tablets film-coated - 300mg+ 200mg

EMCURE IRINOTECAN 40 mg/2 ml INJECTION South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

emcure irinotecan 40 mg/2 ml injection

emcure- pharmaceutical south africa (pty) ltd - injection - see ingredients - each vial contains irinotecan 40,0 mg

EMCURE IRINOTECAN 100 mg/5 ml INJECTION South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

emcure irinotecan 100 mg/5 ml injection

emcure- pharmaceutical south africa (pty) ltd - injection - see ingredients - each vial contains irinotecan 100,0 mg

Pause Injection 500 mg/ 5 ml Tanzania - English - Tanzania Medicinces & Medical Devices Authority

pause injection 500 mg/ 5 ml

emcure pharmaceuticals limited, india - tranexamic acid - injection - 500 mg/ 5 ml

Encifer solution for i/v injection Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

encifer solution for i/v injection

samrudh pharmaceuticals pvt. ltd. - iron sucrose complex - solution for i/v injection - 20mg/ml

Bicnu 100mg powder for injection vial with diluent vial Australia - English - Department of Health (Therapeutic Goods Administration)

bicnu 100mg powder for injection vial with diluent vial

emcure pharmaceuticals pty ltd - carmustine, quantity: 100 mg - injection, powder for - excipient ingredients: - indications as at 16 december 1985: carmustine is indicated as palliative therapy as a single agent or in established combination therapy with other approved chemotherapeutic agents in the following: 1. malignant glioma. 2. multiple myeloma: in combination with prednisone. 3. hodgkin's disease: as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy. 4. non-hodgkins lymphomas: as secondary therapy in combination with other approved drugs for patients who relapse while being treated with primary therapy or who fail to respond to primary therapy.

EMEXED pemetrexed (as disodium) 500 mg powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

emexed pemetrexed (as disodium) 500 mg powder for injection vial

emcure pharmaceuticals pty ltd - pemetrexed disodium hemipentahydrate, quantity: 604.1 mg (equivalent: pemetrexed, qty 500 mg) - injection, powder for - excipient ingredients: mannitol; sodium hydroxide; hydrochloric acid; nitrogen - malignant pleural mesothelioma pemetrexed, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,non-small cell lung cancer pemetrexed in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,pemetrexed as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.